Wow, exciting news! A study done by at the school of medicine at Mount Sinai shows that a growth hormone currently approved by the FDA for treating short stature is "associated with significant improvement in both social impairment and restrictive behaviors in people with Phelan-McDermid."
As these are two of the things that prove to be the most limiting for children in terms of having typical interactions with others, this could be a life changing discovery. Just as is exciting is that this study opens up research regarding the treatment of the symptoms of ASD. The director of the Seaver Autism center at Mount Sinai says "This clinical trial is part of a paradigm shift to develop targeted, disease modifying medicines specifically to treat the core symptons of ASD."
Growth hormone improves social impairments in those with autism-linked disorder
As these are two of the things that prove to be the most limiting for children in terms of having typical interactions with others, this could be a life changing discovery. Just as is exciting is that this study opens up research regarding the treatment of the symptoms of ASD. The director of the Seaver Autism center at Mount Sinai says "This clinical trial is part of a paradigm shift to develop targeted, disease modifying medicines specifically to treat the core symptons of ASD."
Growth hormone improves social impairments in those with autism-linked disorder
No comments:
Post a Comment